{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:15:56Z","timestamp":1778098556130,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032091","name":"Royal Free Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jhepr.2025.101637","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:11:55Z","timestamp":1760659915000},"page":"101637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-9943","authenticated-orcid":false,"given":"Gloryanne","family":"Aidoo-Micah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kucykowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-8418","authenticated-orcid":false,"given":"Nathalie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-0104","authenticated-orcid":false,"given":"Vishnu","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rushabh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayani","family":"Khara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tate","family":"Mckinnon-Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8725-7822","authenticated-orcid":false,"given":"Yiya","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-3777","authenticated-orcid":false,"given":"Daniel Brown","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-9462","authenticated-orcid":false,"given":"Laura","family":"Pallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0537-6715","authenticated-orcid":false,"given":"Leo","family":"Swadling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-0189","authenticated-orcid":false,"given":"Mariana","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Childs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-9708","authenticated-orcid":false,"given":"Upkar","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-5228","authenticated-orcid":false,"given":"Edward","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0782-8647","authenticated-orcid":false,"given":"Tim","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-1462","authenticated-orcid":false,"given":"Mala K.","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101637_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2025.101637_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2025.101637_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib4","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhepr.2025.101637_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.annonc.2024.02.005","article-title":"Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"35","author":"Sangro","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhepr.2025.101637_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib8","article-title":"Immunotherapy for hepatocellular carcinoma","volume":"6","author":"Childs","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101637_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhepr.2025.101637_bib10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gutjnl-2018-316510","article-title":"Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Lim","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101637_bib11","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1038\/s41467-023-43381-1","article-title":"PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma","volume":"14","author":"Cappuyns","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101637_bib12","article-title":"PLAUR+ neutrophils drive anti-PD-1 therapy resistance in patients with hepatocellular carcinoma by Shaping an immunosuppressive microenvironment","author":"Liu","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.jhepr.2025.101637_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12964-025-02070-w","article-title":"Molecular landscape of tumor-associated tissue-resident memory T cells in tumor microenvironment of hepatocellular carcinoma","volume":"23","author":"Park","year":"2025","journal-title":"Cell Commun Signaling"},{"key":"10.1016\/j.jhepr.2025.101637_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101430","article-title":"Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma","author":"Blaise","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101637_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101637_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00281-022-00932-w","article-title":"Liver-resident memory T cells: life in lockdown","volume":"44","author":"Pallett","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhepr.2025.101637_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib18","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201605","article-title":"Tissue-resident memory T cells in tumor immunity and immunotherapy","volume":"218","author":"Ok\u0142a","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41416-021-01535-2","article-title":"Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit","volume":"125","author":"Childs","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2025.101637_bib21","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2018-317071","article-title":"Fine needle aspirates comprehensively sample intrahepatic immunity","volume":"68","author":"Gill","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101637_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2015.04.011","article-title":"Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver","volume":"424","author":"Pembroke","year":"2015","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jhepr.2025.101637_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2015.09.006","article-title":"Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy","volume":"123","author":"Spaan","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2025.101637_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2893.2005.00626.x","article-title":"Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis","volume":"12","author":"Sprengers","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2025.101637_bib25","article-title":"Efficacy of antiviral therapy and host\u2013virus interactions visualised using serial liver sampling with fine-needle aspirates","volume":"5","author":"Kim","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101637_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158903","article-title":"Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells","volume":"133","author":"Nkongolo","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2025.101637_bib27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/HEP.0000000000000438","article-title":"Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients","volume":"78","author":"Genshaft","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101637_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/587936","article-title":"Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations","volume":"2011","author":"Wee","year":"2011","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.jhepr.2025.101637_bib29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gut.2003.032359","article-title":"Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study","volume":"53","author":"Caturelli","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101637_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5009\/gnl17140","article-title":"Slow-pull using a fanning technique is more useful than the standard suction technique in EUS-guided fine needle aspiration in pancreatic masses","volume":"12","author":"Lee","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2025.101637_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0032-1326268","article-title":"Randomized trial comparing fanning with standard technique for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions","volume":"45","author":"Bang","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhepr.2025.101637_bib32","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2025.101637_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41467-022-29012-1","article-title":"Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma","volume":"13","author":"Zakeri","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101637_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/lci2.72","article-title":"T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: implications for immune checkpoint inhibitor therapy","volume":"4","author":"Barsch","year":"2023","journal-title":"Liver Cancer Int"},{"key":"10.1016\/j.jhepr.2025.101637_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib39","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.4049\/jimmunol.179.8.5054","article-title":"The alpha1beta1 integrin and TNF receptor II protect airway CD8+ effector T cells from apoptosis during influenza infection","volume":"179","author":"Richter","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8 + T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2025.101637_bib41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.01.010","article-title":"Functions of human liver CD69+CD103-CD8+ T cells depend on HIF-2\u03b1 activity in healthy and pathologic livers","volume":"72","author":"Kim","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","article-title":"CXC chemokine Ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver","volume":"174","author":"Heydtmann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib43","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2019.01.247","article-title":"CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4+ T-cell\u2013dependent control of senescence","volume":"156","author":"Mossanen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101637_bib44","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/gutjnl-2020-323771","article-title":"The human liver microenvironment shapes the homing and function of CD4 + T-cell populations","volume":"71","author":"Wiggins","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101637_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhepr.2025.101637_bib46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib47","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","article-title":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma","volume":"28","author":"Zhu","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101637_bib48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","article-title":"Antibodies against immune checkpoint molecules restore functions of tumor-infiltrating T cells in hepatocellular carcinomas","volume":"153","author":"Zhou","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101637_bib49","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41577-024-01062-0","article-title":"Defining myeloid-derived suppressor cells","volume":"24","author":"Akkari","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib50","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101637_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104295","article-title":"MDSCs in liver cancer: a critical tumor-promoting player and a potential therapeutic target","volume":"361","author":"Ma","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jhepr.2025.101637_bib52","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jhep.2023.08.024","article-title":"Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells","volume":"79","author":"Meng","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101637_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/srep31745","article-title":"Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironment","volume":"6","author":"Lizotte","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101637_bib55","article-title":"Evaluation of the HBV liver reservoir with fine needle aspirates","volume":"5","author":"Testoni","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101637_bib56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/modpathol.2016.228","article-title":"Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies","volume":"30","author":"Roy-Chowdhuri","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhepr.2025.101637_bib57","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/1878-0261.12952","article-title":"Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage","volume":"15","author":"Franz\u00e9n","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jhepr.2025.101637_bib58","doi-asserted-by":"crossref","unstructured":"Evans J. Clinical trial of whether AZD5069 combined with immunotherapy (durvalumab) is effective for patients with advanced primary liver cancer. Http:\/\/IsrctnCom\/n.d. https:\/\/doi.org\/10.1186\/ISRCTN12669009.","DOI":"10.1186\/ISRCTN12669009"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:44:06Z","timestamp":1778096646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589555925003192"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101637","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101637"}}